Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ameet Sarpatwari, J.D., Ph.D.

Title
Institution
Department
Address
Phone
Other Positions
Title
Institution
Department

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sarpatwari A, Avorn J, Kesselheim AS. Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation? BMJ. 2020 10 08; 371:m3841. PMID: 33032982.
    Citations:    
  2. Lee CC, Kesselheim AS, Sarpatwari A. Clinical Development Times for Biosimilars in the United States. Mayo Clin Proc. 2020 Oct; 95(10):2152-2154. PMID: 33012346.
    Citations:    
  3. Sacks CA, Van de Wiele VL, Fulchino LA, Patel L, Kesselheim AS, Sarpatwari A. Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions. JAMA Intern Med. 2020 Aug 31. PMID: 32865564.
    Citations:    
  4. Bhasale AL, Sarpatwari A, De Bruin ML, Lexchin J, Lopert R, Bahri P, Mintzes BJ. Postmarket Safety Communication for Protection of Public Health: A Comparison of Regulatory Policy in Australia, Canada, the European Union, and the United States. Clin Pharmacol Ther. 2020 Aug 07. PMID: 32767557.
    Citations:    
  5. Barenie RE, Kesselheim AS, Gagne JJ, Lu Z, Campbell EG, Dutcher SK, Jiang W, Sarpatwari A. Preferences for and experiences with pill appearance changes: national surveys of patients and pharmacists. Am J Manag Care. 2020 08; 26(8):340-347. PMID: 32835461.
    Citations:    
  6. Sarpatwari A, Kaltenboeck A, Kesselheim AS. Missed Opportunities on Emergency Remdesivir Use. JAMA. 2020 07 28; 324(4):331-332. PMID: 32579163.
    Citations:    
  7. Beall RF, Ronksley PE, Wick J, Darrow JJ, Sarpatwari A, Kesselheim AS. Comparing Onset of Biosimilar Versus Generic Competition in the United States. Clin Pharmacol Ther. 2020 Jul 04. PMID: 32621540.
    Citations:    
  8. Lauenroth VD, Kesselheim AS, Sarpatwari A, Stern AD. Lessons From The Impact Of Price Regulation On The Pricing Of Anticancer Drugs In Germany. Health Aff (Millwood). 2020 Jul; 39(7):1185-1193. PMID: 32634355.
    Citations:    
  9. Bhasale A, Mintzes B, Sarpatwari A. Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators. BMJ. 2020 04 29; 369:m1107. PMID: 32349976.
    Citations:    
  10. Kim SC, Sarpatwari A, Landon JE, Desai RJ. Utilization and Treatment Costs of Tumor Necrosis Factor Inhibitors After the Introduction of Biosimilar Infliximab in the United States. Arthritis Rheumatol. 2020 06; 72(6):1036-1038. PMID: 31943866.
    Citations:    
  11. Luo J, Kesselheim AS, Sarpatwari A. Insulin access and affordability in the USA: anticipating the first interchangeable insulin product. Lancet Diabetes Endocrinol. 2020 05; 8(5):360-362. PMID: 32203681.
    Citations:    
  12. Kassir Z, Sarpatwari A, Kocak B, Kuza CC, Gellad WF. Sponsorship and Funding for Gene Therapy Trials in the United States. JAMA. 2020 03 03; 323(9):890-891. PMID: 32125392.
    Citations:    
  13. Sarpatwari A, Brown D, Kesselheim AS. Development of a National Public Pharmaceutical Research and Development Institute. J Law Med Ethics. 2020 03; 48(1):225-227. PMID: 32342778.
    Citations:    
  14. Sarpatwari A, LaPidus AK, Kesselheim AS. Revisiting the National Institutes of Health Fair Pricing Condition: Promoting the Affordability of Drugs Developed With Government Support. Ann Intern Med. 2020 03 03; 172(5):348-350. PMID: 31986528.
    Citations:    
  15. Desai RJ, Gopalakrishnan C, Dejene S, Sarpatwari AS, Levin R, Dutcher SK, Wang Z, Wittayanukorn S, Franklin JM, Gagne JJ. Comparative Outcomes of Treatment Initiation With Brand vs. Generic Warfarin in Older Patients. Clin Pharmacol Ther. 2020 Jun; 107(6):1334-1342. PMID: 31872419.
    Citations:    
  16. Kaltenboeck A, Calsyn M, Frederix GWJ, Lowenthal J, Mitchell D, Rector B, Sarpatwari A. Grounding Value-Based Drug Pricing in Population Health. Clin Pharmacol Ther. 2020 Jun; 107(6):1290-1292. PMID: 31953850.
    Citations:    
  17. Desai RJ, Sarpatwari A, Gautam N, Lii J, Fischer MA, Gagne JJ. Changes in Utilization of Generic Angiotensin Receptor Blockers Following Product Recalls in the United States. JAMA. 2020 01 07; 323(1):87-89. PMID: 31910271.
    Citations:    
  18. Jung EH, Sarpatwari A, Kesselheim AS. Novelty of Active Ingredients in High-Cost Brand-Name Drugs. J Gen Intern Med. 2020 Jul; 35(7):2219-2221. PMID: 31898115.
    Citations:    
  19. Jung EH, Sarpatwari A, Kesselheim AS, Sinha MS. Correction to: FDA and EMA Biosimilar Approvals. J Gen Intern Med. 2019 Dec 05. PMID: 31808127.
    Citations:    
  20. Dave CV, Patorno E, Franklin JM, Huybrechts K, Sarpatwari A, Kesselheim AS, Bateman BT. Impact of State Laws Restricting Opioid Duration on Characteristics of New Opioid Prescriptions. J Gen Intern Med. 2019 11; 34(11):2339-2341. PMID: 31309407.
    Citations:    
  21. Jung EH, Sarpatwari A, Kesselheim AS, Sinha MS. FDA and EMA Biosimilar Approvals. J Gen Intern Med. 2020 Jun; 35(6):1908-1910. PMID: 31637641.
    Citations:    
  22. Fernandez Lynch H, Sarpatwari A, Vonderheide RH, Zettler PJ. Right to Try Requests and Oncologists' Gatekeeping Obligations. J Clin Oncol. 2020 01 10; 38(2):111-114. PMID: 31613694.
    Citations:    
  23. Luo J, Kulldorff M, Sarpatwari A, Pawar A, Kesselheim AS. Variation in Prescription Drug Prices by Retail Pharmacy Type: A National Cross-sectional Study. Ann Intern Med. 2019 11 05; 171(9):605-611. PMID: 31569218.
    Citations:    
  24. Gyawali B, Bouche G, Pantziarka P, Kesselheim AS, Sarpatwari A. Lung Cancer Survival Gains: Contributions of Academia and Industry. J Law Med Ethics. 2019 09; 47(3):465-467. PMID: 31560624.
    Citations:    
  25. Zhai MZ, Sarpatwari A, Kesselheim AS. Why Are Biosimilars Not Living up to Their Promise in the US? AMA J Ethics. 2019 08 01; 21(8):E668-678. PMID: 31397662.
    Citations:    
  26. Sarpatwari A, DiBello J, Zakarian M, Najafzadeh M, Kesselheim AS. Competition and price among brand-name drugs in the same class: A systematic review of the evidence. PLoS Med. 2019 07; 16(7):e1002872. PMID: 31361747.
    Citations:    
  27. Sarpatwari A, Kesselheim AS. Reforming the Orphan Drug Act for the 21st Century. N Engl J Med. 2019 Jul 11; 381(2):106-108. PMID: 31291512.
    Citations:    
  28. Stern AD, Pietrulla F, Herr A, Kesselheim AS, Sarpatwari A. The Impact Of Price Regulation On The Availability Of New Drugs In Germany. Health Aff (Millwood). 2019 07; 38(7):1182-1187. PMID: 31260362.
    Citations:    
  29. Hong P, Sarpatwari A, Kesselheim AS. Orphan Drug Designation and Exclusivity for "Same Drugs". J Law Med Ethics. 2019 06; 47(2):347-349. PMID: 31298092.
    Citations:    
  30. Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly JG, Fischer MA, Kesselheim AS, Gagne JJ. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims. PLoS Med. 2019 03; 16(3):e1002763. PMID: 30865626.
    Citations:    
  31. Sarpatwari A, Kesselheim AS. Tepid Steps on Drug Pricing. JAMA Intern Med. 2019 03 01; 179(3):439-441. PMID: 30667462.
    Citations:    Fields:    
  32. Gopalakrishnan C, Gagne JJ, Sarpatwari A, Dejene SZ, Dutcher SK, Levin R, Franklin JM, Schneeweiss S, Desai RJ. Evaluation of Socioeconomic Status Indicators for Confounding Adjustment in Observational Studies of Medication Use. Clin Pharmacol Ther. 2019 06; 105(6):1513-1521. PMID: 30659590.
    Citations:    Fields:    
  33. Sarpatwari A, Curfman G. Mitigating Health Risks of Prescription Drugs: Lessons From FDA Oversight of Opioid Products. JAMA. 2019 02 19; 321(7):651-653. PMID: 30778584.
    Citations:    
  34. Beall RF, Kesselheim AS, Sarpatwari A. New Drug Formulations and Their Respective Generic Entry Dates. J Manag Care Spec Pharm. 2019 Feb; 25(2):218-224. PMID: 30698097.
    Citations:    Fields:    
  35. Sarpatwari A, Gagne JJ, Lu Z, Campbell EG, Carman WJ, Enger CL, Dutcher SK, Jiang W, Kesselheim AS. A Survey of Patients' Perceptions of Pill Appearance and Responses to Changes in Appearance for Four Chronic Disease Medications. J Gen Intern Med. 2019 03; 34(3):420-428. PMID: 30632102.
    Citations:    Fields:    
  36. Rogers JR, Sarpatwari A, Desai RJ, Bohn JM, Khan NF, Kesselheim AS, Fischer MA, Gagne JJ, Connolly JG. Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration's Adverse Event Reporting System. Drug Saf. 2019 01; 42(1):85-93. PMID: 30066315.
    Citations:    Fields:    
  37. Sarpatwari A, Barenie R, Curfman G, Darrow JJ, Kesselheim AS. The US Biosimilar Market: Stunted Growth and Possible Reforms. Clin Pharmacol Ther. 2019 01; 105(1):92-100. PMID: 30415479.
    Citations:    Fields:    
  38. Gagne JJ, Sarpatwari A, Desai RJ. Role of Authorized Generics in Postapproval Surveillance of Generic Drug Products. Clin Pharmacol Ther. 2019 02; 105(2):313-315. PMID: 30593655.
    Citations:    Fields:    
  39. Avorn J, Kesselheim A, Sarpatwari A. The FDA Amendments Act of 2007 - Assessing Its Effects a Decade Later. N Engl J Med. 2018 Sep 20; 379(12):1097-1099. PMID: 30231220.
    Citations:    Fields:    
  40. Lynch HF, Zettler PJ, Sarpatwari A. Promoting Patient Interests in Implementing the Federal Right to Try Act. JAMA. 2018 Sep 04; 320(9):869-870. PMID: 30105394.
    Citations:    Fields:    Translation:Humans
  41. Sarpatwari A, Avorn J, Kesselheim AS. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices. JAMA. 2018 06 19; 319(23):2373-2374. PMID: 29800027.
    Citations: 1     Fields:    
  42. Sarpatwari A, Beall RF, Abdurrob A, He M, Kesselheim AS. Evaluating The Impact Of The Orphan Drug Act's Seven-Year Market Exclusivity Period. Health Aff (Millwood). 2018 05; 37(5):732-737. PMID: 29733729.
    Citations:    Fields:    Translation:Humans
  43. Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly J, Fischer MA, Kesselheim AS, Gagne JJ. Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study. BMJ. 2018 Apr 03; 361:k1180. PMID: 29615391.
    Citations: 3     Fields:    Translation:Humans
  44. Fuse Brown EC, Sarpatwari A. Removing ERISA's Impediment to State Health Reform. N Engl J Med. 2018 Jan 04; 378(1):5-7. PMID: 29298152.
    Citations:    Fields:    
  45. Sarpatwari A, Gluck AR, Curfman GD. The Supreme Court Ruling in Sandoz v Amgen: A Victory for Follow-on Biologics. JAMA Intern Med. 2018 01 01; 178(1):5-6. PMID: 29131908.
    Citations:    Fields:    
  46. Curfman GD, Beletsky L, Sarpatwari A. Benefits, Limitations, and Value of Abuse-Deterrent Opioids. JAMA Intern Med. 2018 01 01; 178(1):131-132. PMID: 29228102.
    Citations:    Fields:    
  47. Sarpatwari A, Lee MP, Gagne JJ, Lu Z, Dutcher SK, Jiang W, Campbell EG, Kesselheim AS. Generic Versions of Narrow Therapeutic Index Drugs: A National Survey of Pharmacists' Substitution Beliefs and Practices. Clin Pharmacol Ther. 2018 06; 103(6):1093-1099. PMID: 29165800.
    Citations:    Fields:    
  48. Vokinger KN, Kesselheim AS, Avorn J, Sarpatwari A. Strategies That Delay Market Entry of Generic Drugs. JAMA Intern Med. 2017 11 01; 177(11):1665-1669. PMID: 28975217.
    Citations:    Fields:    Translation:Humans
  49. Sarpatwari A, Choudhry NK. Recalibrating Privacy Protections to Promote Patient Engagement. N Engl J Med. 2017 Oct 19; 377(16):1509-1511. PMID: 29045208.
    Citations:    Fields:    Translation:Humans
  50. Hwang TJ, Kesselheim AS, Sarpatwari A. Value-Based Pricing and State Reform of Prescription Drug Costs. JAMA. 2017 08 15; 318(7):609-610. PMID: 28692713.
    Citations:    Fields:    
  51. Wang B, Studdert DM, Sarpatwari A, Franklin JM, Landon J, Kesselheim AS. The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine. PLoS One. 2017; 12(4):e0175313. PMID: 28388667.
    Citations:    Fields:    
  52. Sarpatwari A, Gagne JJ, Levidow NL, Kesselheim AS. Active Surveillance of Follow-on Biologics: A Prescription for Uptake. Drug Saf. 2017 02; 40(2):105-108. PMID: 27838823.
    Citations:    Fields:    Translation:Humans
  53. Kesselheim AS, Rome BN, Sarpatwari A, Avorn J. Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug Makers. Health Aff (Millwood). 2017 02 01; 36(2):362-370. PMID: 28100464.
    Citations:    Fields:    Translation:Humans
  54. Sarpatwari A, Avorn J, Kesselheim AS. Factors Influencing Prescription Drug Costs in the United States-Reply. JAMA. 2016 12 13; 316(22):2431-2432. PMID: 27959994.
    Citations:    Fields:    Translation:Humans
  55. Kesselheim AS, Avorn J, Sarpatwari A. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform. JAMA. 2016 Aug 23-30; 316(8):858-71. PMID: 27552619.
    Citations: 22     Fields:    Translation:Humans
  56. Yeh JS, Sarpatwari A, Kesselheim AS. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels. Drug Saf. 2016 08; 39(8):709-14. PMID: 27000800.
    Citations:    Fields:    Translation:Humans
  57. Sarpatwari A, Kesselheim AS. Navigating the Dermatological Drug Cost Curve. JAMA. 2016 Jun 28; 315(24):2724-5. PMID: 27367767.
    Citations:    Fields:    Translation:Humans
  58. Sarpatwari A, Avorn J, Kesselheim AS. State Initiatives to Control Medication Costs--Can Transparency Legislation Help? N Engl J Med. 2016 Jun 16; 374(24):2301-4. PMID: 27305189.
    Citations: 6     Fields:    Translation:Humans
  59. Sarpatwari A, Gagne JJ. Balancing benefits and harms: privacy protection policies. Pharmacoepidemiol Drug Saf. 2016 08; 25(8):969-71. PMID: 27278106.
    Citations:    Fields:    
  60. Sarpatwari A, Kesselheim AS. Efficacy of the Priority Review Voucher Program. JAMA. 2016 Apr 19; 315(15):1660-1. PMID: 27092839.
    Citations:    Fields:    Translation:Humans
  61. Sarpatwari A, Kesselheim AS. The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry? PLoS Med. 2016 Feb; 13(2):e1001955. PMID: 26859662.
    Citations:    Fields:    Translation:Humans
  62. Luo J, Sarpatwari A, Kesselheim AS. Regulatory Solutions to the Problem of High Generic Drug Costs. Open Forum Infect Dis. 2015 Dec; 2(4):ofv179. PMID: 26693494.
    Citations: 2     
  63. Kesselheim AS, Maggs LR, Sarpatwari A. Experience With the Priority Review Voucher Program for Drug Development. JAMA. 2015 Oct 27; 314(16):1687-8. PMID: 26414802.
    Citations: 9     Fields:    Translation:Humans
  64. Sarpatwari A, Kesselheim AS. The 21st century cures act: Opportunities and challenges. Clin Pharmacol Ther. 2015 Dec; 98(6):575-7. PMID: 26264909.
    Citations:    Fields:    Translation:HumansPHPublic Health
  65. Avorn J, Sarpatwari A, Kesselheim AS. Forbidden and Permitted Statements about Medications--Loosening the Rules. N Engl J Med. 2015 Sep 03; 373(10):967-73. PMID: 26332553.
    Citations: 4     Fields:    Translation:Humans
  66. Sarpatwari A, Avorn J, Kesselheim AS. Progress and Hurdles for Follow-on Biologics. N Engl J Med. 2015 Jun 18; 372(25):2380-2. PMID: 25946143.
    Citations: 6     Fields:    
  67. Sarpatwari A, Darrow JJ, Kesselheim AS. Expanded access to investigational drugs. N Engl J Med. 2015 04 09; 372(15):1473-4. PMID: 25853762.
    Citations: 1     Fields:    Translation:Humans
  68. Sarpatwari A, Choudhry NK, Avorn J, Kesselheim AS. Paying physicians to prescribe generic drugs and follow-on biologics in the United States. PLoS Med. 2015 Mar; 12(3):e1001802. PMID: 25781468.
    Citations: 4     Fields:    Translation:Humans
  69. Darrow JJ, Sarpatwari A, Avorn J, Kesselheim AS. Practical, legal, and ethical issues in expanded access to investigational drugs. N Engl J Med. 2015 Jan 15; 372(3):279-86. PMID: 25587952.
    Citations: 14     Fields:    Translation:Humans
  70. Sarpatwari A, Franklin JM, Avorn J, Seeger JD, Landon JE, Kesselheim AS. Are risk evaluation and mitigation strategies associated with less off-label use of medications? The case of immune thrombocytopenia. Clin Pharmacol Ther. 2015 Feb; 97(2):186-93. PMID: 25670524.
    Citations: 1     Fields:    Translation:Humans
  71. Sarpatwari A, Kesselheim AS, Malin BA, Gagne JJ, Schneeweiss S. Ensuring patient privacy in data sharing for postapproval research. N Engl J Med. 2014 Oct 23; 371(17):1644-9. PMID: 25337755.
    Citations: 5     Fields:    Translation:Humans
  72. Sarpatwari A, Avorn J, Kesselheim AS. Using a drug-safety tool to prevent competition. N Engl J Med. 2014 Apr 17; 370(16):1476-8. PMID: 24738666.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  73. Anzures-Cabrera J, Sarpatwari A, Higgins JP. Expressing findings from meta-analyses of continuous outcomes in terms of risks. Stat Med. 2011 Nov 10; 30(25):2967-85. PMID: 21826697.
    Citations: 11     Fields:    Translation:Humans
  74. Sarpatwari A, Bussel JB, Ahmed M, Erqou S, Semple JW, Newland AC, Bennett D, Pharoah P, Provan D. Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults. Hematology. 2011 Jul; 16(4):243-8. PMID: 21756542.
    Citations: 3     Fields:    Translation:Humans
  75. Sarpatwari A, Provan D, Erqou S, Sobnack R, David Tai FW, Newland AC. Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry. Br J Haematol. 2010 Dec; 151(5):477-87. PMID: 20950403.
    Citations: 11     Fields:    Translation:HumansCells
  76. Sarpatwari A, Watson S, Erqou S, Anderson H, Grainger J, Higgins JP, Newland AC. Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP). Br J Haematol. 2010 Oct; 151(2):189-91. PMID: 20666773.
    Citations:    Fields:    Translation:Humans
  77. Sarpatwari A, Bennett D, Logie JW, Shukla A, Beach KJ, Newland AC, Sanderson S, Provan D. Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database. Haematologica. 2010 Jul; 95(7):1167-75. PMID: 20145266.
    Citations: 18     Fields:    Translation:Humans
  78. Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, Provan D, Newland A, Amadori S, Bussel JB. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2009 Feb 05; 113(6):1231-40. PMID: 18945961.
    Citations: 48     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu. SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Sarpatwari's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (222)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.